Drug firm JB Chemicals and Pharmaceuticals Ltd on Tuesday (March 24) announced the appointment of Aman Mehta as managing director for a three-year term effective January 21, 2026.
Mehta, currently Managing Director at Torrent Pharmaceuticals Limited, holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York. He brings over a decade of experience in strategic growth, M&A integration, and market expansion.
Mehta has been instrumental in accelerating the growth of Torrent Pharma through a combination of organic initiatives and strategic acquisitions. His key contributions in the India business have been the identification and integration of assets for M&A (Unichem, Curatio, etc) and driving organic growth in Torrent Pharma’s India business, led by the field force expansion, in-licensing, and entry into new therapeutic areas.
Also Read: Torrent Pharma shares gain 4% after steady Q3; Street positive on JB merger benefits
JB Chemicals also appointed four non-executive, non-independent directors: Amal Kelshikar, Hasmukh Patel, and Sudhir Menon, besides Aman Mehta, all effective March 23, 2026.
Amal Kelshikar has 32 years of experience across strategic planning, marketing, sales, and licensing. He holds a BE (Chem) from the University Department of Chemical Technology, Mumbai, and an MBA (PGDM) from the Indian Institute of Management, Ahmedabad, with additional executive programmes from Harvard Business School and Kellogg Executive Education.
Hasmukh Patel, with over 33 years in the pharmaceutical sector, has held senior leadership roles at Torrent Pharmaceuticals, focusing on manufacturing, supply chain, API development, and product development. He holds a master’s degree in pharmacy.
Also Read: JB Chemicals and Pharma Q3 Results: Profit up 22% as domestic biz outpaces market
Sudhir Menon, a chartered and cost accountant, brings 29 years of experience in finance and corporate management. He is executive director (finance) and CFO at Torrent Pharmaceuticals Limited, overseeing finance, legal, IT, and investor relations.
Shares of JB Chemicals and Pharmaceuticals Ltd ended at ₹2,071.80, down by ₹11.05, or 0.53%, on the BSE today, March 24.
